Daptomycin activity tested against 164 457 bacterial isolates from hospitalised patients: Summary of 8 years of a Worldwide Surveillance Programme (2005-2012)

International Journal of Antimicrobial Agents

Volumn 43, Issue 5, 2014, Pages 465-469

  Sader, Helio S ^a   Farrell, David J ^a   Flamm, Robert K ^a   Jones, Ronald N ^a  

^a JMI LABORATORIES   (United States)

Author keywords

Antimicrobial resistance; Bacteraemia; Gram positive infections; Hospital acquired infections

Indexed keywords

DAPTOMYCIN; LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; BROTH DILUTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TREND STUDY; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; GRAM POSITIVE BACTERIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HEALTH; HOSPITAL PATIENT; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PREVALENCE;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; GLOBAL HEALTH; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INPATIENTS; MICROBIAL SENSITIVITY TESTS; PREVALENCE;

EID: 84899513035     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.01.018     Document Type: Article

References (14)

1. Cubicin package insert, 2013. http://www.cubicin.com/pdf/ PrescribingInformation.pdf (USA); and http://www.ema.europa.eu/ema/index.jsp? curl = pages/medicines/human/medicines/000637/human-med-000730.jsp&mid= WC0b01ac058001d124 (Europe) [accessed October 2013].
2. D.P. Levine Clinical experience with daptomycin: bacteremia and endocarditis J Antimicrob Chemother 62 2008 iii35 iii39
3. I.M. Gould, J.M. Miró, and M.J. Rybak Daptomycin: the role of high-dose and combination therapy for Gram-positive infections Int J Antimicrob Agents 42 2013 202 210
4. K.P. Murray, J.J. Zhao, S.L. Davis, R. Kullar, K.S. Kaye, and P. Lephart et al. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteraemia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study Clin Infect Dis 56 2013 1562 1569
5. U. Bertsche, C. Weidenmaier, D. Kuehner, S.J. Yang, S. Baur, and S. Wanner et al. Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and d-alanylation Antimicrob Agents Chemother 55 2011 3922 3928
6. N.N. Mishra, A.S. Bayer, P.A. Moise, M.R. Yeaman, and G. Sakoulas Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients J Infect Dis 206 2012 1160 1167
7. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. Document M100-S23 2013 CLSI Wayne, PA
8. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 3.0 2013 http://www.eucast.org/clinical-breakpoints/ [accessed 2.01.13]
9. ® package insert, 2012. http://www.tygacil.com [accessed September 2013].
10. A. Gonzalez-Ruiz, A. Beiras-Fernandez, H. Lehmkuhl, R.A. Seaton, J. Loeffler, and R.L. Chaves Clinical experience with daptomycin in Europe: the first 2.5 years J Antimicrob Chemother 66 2011 912 919
11. K.V. Rolston, D. Besece, K.C. Lamp, M. Yoon, S.A. McConnell, and P. White Daptomycin use in neutropenic patients with documented Gram-positive infections Support Care Cancer 22 2014 7 14
12. S.J. Yang, B.N. Kreiswirth, G. Sakoulas, M.R. Yeaman, Y.Q. Xiong, and A. Sawa et al. Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus J Infect Dis 200 2009 1916 1920
13. Y.H. Chen, C.Y. Liu, W.C. Ko, C.H. Liao, P.L. Lu, and C.H. Huang et al. Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010 Eur J Clin Microbiol Infect Dis 33 2014 233 239
14. T.M. Kao, J.T. Wang, C.M. Weng, Y.C. Chen, and S.C. Chang In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC J Microbiol Immunol Infect 44 2011 346 351